Sodium channel drugs and uses
The compounds of this invention comprise 2-10 ligands covalently connected, each of the ligands being capable of binding to a ligand binding site in a Na+ channel, thereby modulating the biological activities thereof.
Theravance, Inc.
A C
A61K C07D
inventional inventional
Scott Seok-Ki David T. Daniel Thomas E. Timothy J. John H. David C.
Armstrong Choi Beattie Marquess Jenkins Church Griffin Green